Training activity information


Clinically interpret results of chimerism analysis to assess and monitor patients post HSCT


Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.


  • Involvement of the wider multidisciplinary team and other specialties
  • Local protocols for the clinical and laboratory monitoring of patients who have received HSCT
  • Conditioning regimens and applicability of chimerism analysis
  • Immunosuppression regimes
  • Principles of methods employed for post-transplant monitoring including sensitivity and specificity
  • Cell lineage analysis
  • National guidelines for chimerism analysis
  • Applicability of chimerism analysis for malignant and non-malignant conditions
  • HSCT complications
  • Patient centred care and support impact of the chimerism results for the patient including treatment options

Relevant learning outcomes

# Outcome
# 3 Outcome

Perform clinical and laboratory monitoring of patients who have received HSCT.

# 4 Outcome

Practice effectively in partnership with other clinical specialisms and the wider multidisciplinary team in the investigation of HSCT to deliver safe and effective patient care.